Whenever there is widespread uncertainty about the balance between the benefits and harms of a therapeutic intervention—which clearly exists for the timing of when to start […]
A study led by researchers at Baylor College of Medicine reveals a novel role of the steroid receptor coactivator 3 (SRC-3/NCOA3), a protein crucial for steroid […]
(HealthDay)—Tirbanibulin is superior to vehicle at two months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence […]